This is the authors' abstract. We don't add key points for this paper.
This is a scientific literature review of a large selection of studies drawn from medical research publications databases, including PubMed, bioRxiv and ResearchGate. Its particular focus concerns the therapeutic benefits and mode of action of baicalin and its associated flavonoids. Broad spectrum in nature, Baicalin can act as tumor suppressor, it has antiviral and neuroprotective properties and is a source of phytomelatonin. It works systemically and quickly breaks down to form metabolites including baicalein and woganin, also with therapeutic properties. It can be used to treat endometriosis, ulcerative colitis, ME, CFS and MS, due its ability to stimulate remyelination. Dosing, contraindications and administration in a clinical setting are then considered to conclude the review.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Cowley et al. (2022) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: